Lorcaserin in the Treatment of Cocaine Use Disorder

• Status: Completed
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to evaluate the efficacy and safety of lorcaserin in the treatment of cocaine use disorder.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National Institute on Drug Abuse (NIDA)
• Treatments: Cocaine

Criteria

Inclusion Criteria:

• Has a DSM-5 diagnosis of current cocaine use disorder as verified by the Structured Clinical Interview for DSM-5

• Is seeking treatment for cocaine use disorder

• Is able to understand and provide written informed consent

• Has used cocaine on at least 1 day in the last 30 days prior to screening

• Has completed all psychological assessments and procedures during the screening period

• If female, not pregnant, lactating, unable to conceive OR must agree to use an acceptable method of birth control

• Has a total body weight greater than 110 pounds and body mass index greater than 20

Exclusion Criteria:

• Contact site for more information